{"disease":{"id":"hematologic-cancers","name":"hematologic cancers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06296368","title":"DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02304809","title":"Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":216,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT03512340","title":"Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Surface Oncology","has_results":false},{"nct_id":"NCT06689332","title":"Improving Quality of Life in Frail, Older Patients with Hematological Cancer Through Geriatric Assessment and Treatment - a Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT01943292","title":"Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Verastem, Inc.","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}